SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001567619-22-020443
Filing Date
2022-11-16
Accepted
2022-11-16 15:48:59
Documents
1
Period of Report
2022-11-14

Document Format Files

Seq Description Document Type Size
1 FORM 3 doc1.html 3  
1 FORM 3 doc1.xml 3 3013
  Complete submission text file 0001567619-22-020443.txt   4400
Mailing Address 156 S. FIRST STREET ZIONSVILLE IN 46077
Business Address
Leonard Braden Michael (Reporting) CIK: 0001373603 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-39041 | Film No.: 221395075

Mailing Address 400 OYSTER POINT BOULEVARD SUITE 221 SOUTH SAN FRANCISCO CA 64080
Business Address 400 OYSTER POINT BOULEVARD SUITE 221 SOUTH SAN FRANCISCO CA 64080 415-505-0809
Satsuma Pharmaceuticals, Inc. (Issuer) CIK: 0001692830 (see all company filings)

IRS No.: 813039831 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations